JINS HOLDINGS Inc.

3046.T
Medical Instruments & Supplies
2026/07/10 Updated
Market Cap: $1.2B (¥187.7B)
Stock Price: $49.53 (¥8,040)
Exchange Rate: 1 USD = ¥162.34

Q3 Financial Summary for the 2026 Fiscal Year (August 2026) [Japanese GAAP] (Consolidated)

disclosed revenue of 80,730 million yen, operating profit of 8,892 million yen, net income of 6,241 million yen, etc. Domestic eyewear business is solid, but overseas markets continue to face a lag in demand recovery. The full-year outlook revisions, if any, can be confirmed in the body. Segment-level revenue and profit are disclosed, with YoY comparisons for the third-quarter cumulative results provided.

Importance:
Page Updated: July 10, 2026
IR Disclosure Date: July 10, 2026

Key Figures

  • Revenue: 80,730百万円
  • Gross profit: 70,799百万円
  • Operating profit: 8,892百万円
  • Net income: 6,241百万円
  • Segmented revenue/profit: disclosed (see body)

AI要約

Overview of Performance

This financial summary reports on the consolidated results for the third quarter of the fiscal year ending August 2026, recording revenue of 80,730 million yen, operating profit of 8,892 million yen, and net income of 6,241 million yen. The domestic eyewear business is steady, while overseas markets continue to show delayed demand recovery. Breakdowns of revenue and profit by segment are disclosed, with a comparison to the full-year plan available in the accompanying materials.

Impact on Shareholders and Outlook

The earnings release does not explicitly state whether the full-year outlook has been revised; however, the segment results, capital structure, and cash flow status are presented, and the outlook is likely to be reevaluated depending on market recovery. Progress in overseas operations and cost management will be key focal points.

Operating Profit Trend

JINS Holdings, Inc.

Company overview · Stock price · Financial data · All IR

View company page →